DR. WENDELL BOULWARE

MDReal-Time Hydrated
Specialty: Anesthesiology
Practice Location: WASHINGTON, DC 20037
NPI Number: 1336111392
LIFETIME INDUSTRY VALUE
$209
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BOULWARE is a verified Anesthesiology practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. BOULWARE had an overall industry promotional and research financial footprint of $209 as recorded in the federal CMS Open Payments database.

  • $209 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. BOULWARE's primary funding source is PACIRA PHARMACEUTICALS INCORPORATED, which accounts for $143 (representing 68.6% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$143$72$0$02021$02022$02023$652024$1432025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PACIRA PHARMACEUTICALS INCORPORATED
Rank 1
$143
68.6%
MERCK SHARP & DOHME
Rank 2
$45
21.7%
FISHER & PAYKEL HEALTHCARE
Rank 3
$20
9.7%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.